Related Experiment Video
Updated: Jul 10, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
A cardiologist view of vascular disease in diabetes
Christopher J Lockhart1, Paul K Hamilton, Katherine A McVeigh
1Department of Therapeutics and Pharmacology, School of Medicine, Queens university, Belfast, UK.
Insights
Diabetes significantly increases cardiovascular risks, leading to higher mortality and complications like heart failure and stroke. Aggressive management of risk factors and targeted therapies are crucial for preventing vascular events in diabetic patients.
Area of Science:
- Cardiology
- Endocrinology
- Vascular Biology
Background:
- Diabetes mellitus is a major risk factor for diverse cardiovascular (CV) complications.
- Diabetic metabolic changes disrupt vascular health, increasing end-organ damage and CV events.
- Diabetic patients face higher mortality from acute coronary syndromes and increased risk of heart failure, stroke, and peripheral vascular disease.
Purpose of the Study:
- To outline the significant cardiovascular risks associated with diabetes mellitus.
- To emphasize the importance of aggressive risk factor management and targeted therapies in diabetic patients.
- To highlight the need for improved understanding of vascular biology for novel therapeutic development.
Main Methods:
- Review of existing literature on diabetes and cardiovascular complications.
- Analysis of the impact of diabetes on blood rheology, arterial structure, and endothelial function.
- Discussion of current therapeutic strategies including risk factor control, medical therapy, and revascularization.
Main Results:
- Diabetes significantly elevates the risk of acute coronary syndromes, chronic cardiac failure, stroke, renal failure, and peripheral vascular disease.
- Aggressive management of blood glucose, lipids, and blood pressure is essential for optimal cardiac care.
- Medical therapies targeting plaque stability and platelet activity reduce event frequency.
Conclusions:
- Preventing vascular events is the primary therapeutic goal for patients with diabetes.
- Comprehensive management including risk factor control, targeted medications, and revascularization is necessary.
- Further research into vascular biology is critical for developing new treatments to improve outcomes in diabetic patients.
Abstract:
Diabetes mellitus is a potent risk factor for the development of a wide spectrum of cardiovascular (CV) complications. The complex metabolic milieu accompanying diabetes alters blood rheology, the structure of arteries and disrupts the homeostatic functions of the endothelium. These changes act as the substrate for end-organ damage and the occurrence of CV events. In those who develop acute coronary syndromes, patients with diabetes are more likely to die, both in the acute phase and during follow-up. Patients with diabetes are also more likely to suffer from chronic cardiac failure, independently of the presence of large vessel disease, and also more likely to develop stroke, renal failure and peripheral vascular disease. Preventing vascular events is the primary goal of therapy. Optimal cardiac care for the patient with diabetes should focus on aggressive management of traditional CV risk factors to optimize blood glucose, lipid and blood pressure control. Targeting medical therapy to improve plaque stability and diminish platelet hyper-responsiveness reduces the frequency of events associated with atherosclerotic plaque burden. In patients with critical lesions, revascularization strategies, either percutaneous or surgical, will often be necessary to improve symptoms and prevent vascular events. Improved understanding of the vascular biology will be crucial for the development of new therapeutic agents to prevent CV events and improve outcomes in patients with diabetes.
Related Concept Videos
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Diabetic Retinopathy
Complications of Diabetes Mellitus
Type I Diabetes II: Pathophysiology